OS THERAPIES INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award
OS THERAPIES INCORPORATED (OSTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award of 12.50 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward · last filed 2026-03-31
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 month 12.50K shares.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 1 month 12.50K shares.
- 2023-03-01: Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 12.50K shares; Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award as first filed 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 month |
|---|---|---|---|---|
| 2025-06-30 | 12.50K shares 10-Q · filed 2025-08-18 | |||
| 2023-03-31 | 12.50K shares 10-K · filed 2026-03-31 | |||
| 2023-03-01 | 12.50K shares 10-Q · filed 2025-05-15 | 25.00K shares 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |